The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AIMD | +14.16% | -96.83% | -49.82% | -100% |
| S&P | +13.22% | +85.17% | +13.11% | +934% |
Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. Its Medtech Solutions include COVID-19 Antigen Rapid Test Kit, VOC POCT – Ainos Flora, VOC POCT – Ainos Pen, VOC POCT – CHS430, Very Low-Dose Oral Interferon Alpha, and Synthetic RNA. The company was founded in June 1984 and is headquartered in San Diego, CA.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$1.20M | -220183.5% |
| Gross Margin | -55604.57% | 0.0% |
| Market Cap | $16.49M | 149.3% |
| Market Cap / Employee | $0.37M | 0.0% |
| Employees | 44 | -4.3% |
| Net Income | -$2.93M | 20.8% |
| EBITDA | -$1.58M | 13.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.13M | -78.1% |
| Accounts Receivable | $0.00M | 0.0% |
| Inventory | 0.2 | 3.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $11.00M | 22.2% |
| Short Term Debt | $0.00M | -100.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -55.34% | -5.9% |
| Return On Invested Capital | -2.28% | -214.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1.19M | 19.6% |
| Operating Free Cash Flow | -$1.18M | 19.7% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.45 | 0.64 | 1.06 | 1.29 | 252.06% |
| Price to Sales | 339.37 | 73.37 | 105.22 | 139.61 | 5.02% |
| Price to Tangible Book Value | -4.59 | -4.60 | -1.02 | -1.47 | -55.84% |
| Enterprise Value to EBITDA | -4.40 | -8.64 | -8.40 | -16.26 | 137.37% |
| Return on Equity | -74.4% | -82.9% | -97.8% | -106.6% | 50.96% |
| Total Debt | $12.00M | $12.00M | $11.00M | $11.00M | -10.35% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
